Thailand might order 200,000 courses of anti-COVID drugs from Merck
Category: #health  By Mateen Dalal  Date: 2021-10-05
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

Thailand might order 200,000 courses of anti-COVID drugs from Merck

Thailand’s government is reportedly in talks with U.S. Pharmaceutical giant Merck & Co. to order 200,000 courses of the company’s experimental anti-viral COVID pills.

Confirming the news, the Director-general of the Department of Medical Services of Thailand, Somsak Akksilp stated that the country is presently working on a buying agreement for the medicine. He further said that a consignment of 200,000 courses has been pre-booked and is likely to arrive by December.

Notably, the drug will be made available for public use only after it receives due approval from the U.S. Food and Drug Administration (FDA) as well as the Thai regulator, added Akksilp.

Several Asian countries are trying to get their hands on this potential treatment after falling behind other Western nations in vaccine procurement, due to the acute pinch in supply volumes.

Sources claim that Malaysia, Taiwan, and South Korea are in the queue to buy the new drug from Merck. Meanwhile, the Philippines has already begun a trial on these pills and hopes for it to show efficient results.

Maria Rosario Vergeire, Health Undersecretary of the Philippines was quoted saying that the nation is eligible to have higher access to this treatment as they have the scientific trial counterpart.

The anti-COVID drug, known as molnupiravir is the first-ever oral medication for the treatment of coronavirus disease. Interim trials suggest that it could reduce the chance of death or hospitalization in high-risk patients by 50%. According to sources, the pill works by introducing errors to the genetic code of the virus.

Merck is anticipating a production volume of at least 10 million courses of this antiviral drug by the end of the year. The company recently announced an agreement to supply 1.7 million courses at a price of USD 700 each to the U.S government.

The pharma giant has also stated that the cost of the medicine will be based on the level of income in each of the nations.

Source credits-

https://kfgo.com/2021/10/04/thailand-in-talks-with-merck-for-200000-courses-of-anti-covid-pills/

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal     twitter

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More..

More News By Mateen Dalal

EVs could capture 50% revenue share of major markets by 2030: Report

EVs could capture 50% revenue share of major markets by 2030: Report

By Mateen Dalal

According to a report provided by KPMG, more than 50% of the total vehicle sales will be controlled by the EV segment by 2030. Electric vehicles are rapidly gaining a large share in the mainstream global automobile market. With electric two-wheelers...

Tesla app outage led to several drivers being locked out of their cars

Tesla app outage led to several drivers being locked out of their cars

By Mateen Dalal

Several owners took to social media to vent out as they were unable to utilize their vehicles due to the app outage. CEO Elon Musk has apologized and guaranteed that it does not re-occur in the future. Several Tesla owners were reportedly una...

EU lawmakers agree on new terms for regulating Big Tech companies

EU lawmakers agree on new terms for regulating Big Tech companies

By Mateen Dalal

European Union lawmakers have reportedly settled on new terms for targeting Big Tech companies, an effort to reduce anti-competitive practices in the digital world. According to sources, major political parties in the European Parliament agreed to a...